Previous 10 | Next 10 |
2023-06-05 12:21:29 ET While Optum's $100 a share all-cash bid for Amedisys ( NASDAQ: AMED ) came as a surprise, the deal will likely be able to clear antitrust approval, according to analysts at Jefferies and UBS. "The news came as a surprise to us, particularly after UNH recen...
2023-06-05 11:40:57 ET Shares of home healthcare solutions company Amedisys (NASDAQ: AMED) were up more than 14% Monday morning after the company reported that it had received an unsolicited buyout offer from Optum, a branch of UnitedHealth Group . The stock is up more than ...
2023-06-05 10:19:17 ET Option Care ( NASDAQ: OPCH ) is expected to have a difficult time getting the shareholder vote needed for a stock deal with Amedisys ( NASDAQ: AMED ). Option Care ( OPCH ) was going to have a "very hard time" getting the vote, according to CNBC...
2023-06-05 10:06:47 ET Gainers: Timber Pharmaceuticals ( TMBR ) +36% . Amedisys ( AMED ) +15% . Rockwell Medical ( RMTI ) +15% . Coeptis Therapeutics ( COEP ) +14% . BiondVax Pharmaceuticals ( BVXV ) +12% . Losers: Bellerophon ...
2023-06-05 09:09:40 ET Amedisys ( NASDAQ: AMED ) shares jump 15.5% premarket on Monday after the firm announces engaging in discussions with Optum, to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100/share. Opti...
Amedisys Board Determines Optum Proposal Could Reasonably be Expected to Result in a Superior Proposal Amedisys Engaging in Discussions with Optum BATON ROUGE, La., June 05, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (“Amedisys” or the “Compan...
2023-05-22 02:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-16 08:02:06 ET Summary Infusion services provider Option Care Health is acquiring home healthcare provider Amedisys. The merger spread currently stands at 9%, implying a potential 18%+ IRR. The spread seems to exist due to uncertainty around OPCH’s shareholder a...
2023-05-12 10:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-03 16:56:15 ET Amedisys press release ( NASDAQ: AMED ): Q1 Non-GAAP EPS of $1.00 beats by $0.12 . Revenue of $556.39M (+2.0% Y/Y) misses by $2.59M . For further details see: Amedisys Non-GAAP EPS of $1.00 beats by $0.12, revenue of $556.39M misses...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...